efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis (vol 11, pg 1631, 2022)

Xiaoxiong Xu,Linsong Chen,Dongliang Bian,Jiawei Wu,Alfredo Addeo,Yoshikane Yamauchi,Farkhad Manapov, Wolfram C. M. Dempke,Jacopo Vannucci,Alessandro Di Federico,Siming Jiang,Yicheng Xiong

Translational lung cancer research（2022）

引用 0|浏览4

暂无评分

摘要

For stage IIIA SCLC patients, complete resection combined with chemotherapy might improve the prognosis than patients without surgery. Post-NAC lobectomy was not found to be superior to sub-lobectomy, while pneumonectomy was considered suitable for central-type IIIA-SCLC patients after NAC treatment.

查看译文

关键词

Small cell lung cancer (SCLC),limited disease,neoadjuvant chemotherapy (NAC),surgery

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要